ANA Ananda Developments Plc

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

Change of Location for General Meeting (GM)

Ananda Developments plc (AQSE: ANA), a life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions, announces that the location of the upcoming General Meeting (GM), previously scheduled to be held at 2.00pm today at the offices of Shakespeare Martineau LLP, 60 Floor, 60 Gracechurch Street, London EC3V 0HR, has been changed.

Due to unforeseen security concerns and the closure of the current venue, we have made the decision to move the GM to a new location to ensure the safety and comfort of all attendees.

The GM will now take place at:

40 Gracechurch Street, London, EC3V 0BT

Date and time of the GM remain unchanged.

We apologise for any inconvenience this may cause and appreciate your understanding as we prioritize the safety of our shareholders and stakeholders.

Please ensure that you update your records with the new venue information. Should you have any questions or require further assistance, please contact our investor relations team at ir@anandadevelopments.com. 

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

For more information please contact:

About Ananda Developments

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.

For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.

https://investors.anandadevelopments.com/link/mPqxKr